title: [Photodynamic therapy with verteporfin in treating the choroidal neovascularisation secondary to multifocal choroiditis].
abstract: Apart from AMD and pathologic myopia the posterior uveitis is the most common pathology being the cause of secondary choroidal neovascularisation (CNV). For many years the method of choice in treating those pathologies was the theramal laser photocoagulation with obvious limitations in the cases of subfoveal CNV. The implementation of PDT modality to every day's clinical practice expanded the range of CNV treatment methods. The following case report shows the results of treating the CNV secondary to multifocal choroiditis with PDT. During the 6 months of follow-up period we consider PDT as an effective, safe modality in treating the CNV secondary to inflammation. In the result of single PDT therapy the VA improvement of 4 ETDRS lines and it's stabilization on the level of 20/25 with the decrease of metamorphopsia was gained.
authors.affiliation: Z Katedry i Kliniki Chorób Oczu Akademii Medycznej w Gdańsku.
authors.forename: Andrzej
authors.initials: A
authors.lastname: Gebka
authors.forename: Krystyna
authors.initials: K
authors.lastname: Raczyńska
authors.forename: Cezary
authors.initials: C
authors.lastname: Ciechanowski
authors.forename: Jarosława
authors.initials: J
authors.lastname: Krajka-Lauer
mesh_terms: D000368:Aged; D020256:Choroidal Neovascularization / Q000150:complications* / Q000188:drug therapy*; D002833:Choroiditis / Q000150:complications*; D005260:Female; D006801:Humans; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D000077362:Verteporfin
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin